Abstract:PURPOSE:Molecular biomarkers, especially serologic factors, have been widely applied in cancer diagnosis and patient follow-up. However, there are few valuable prognostic factors in penile squamous cell carcinoma (PSCC). Here, the authors investigated whether laminin gamma 2 (LAMC2) expression, especially serum LAMC2 (sLAMC2) level, was a suitable prognostic factor that could aid in the prediction of survival in PSCC.PATIENTS AND METHODS:This study included 114 PSCC patients. Reverse transcription-quantitative polymerase chain reaction, Western blotting, and immunohistochemistry were performed to detect LAMC2 expression; enzyme-linked immunosorbent assays were used to test sLAMC2 concentration; and a Transwell assay and an in vivo experiment in nude mice were used to test PSCC cell migration, invasion, and metastasis. The chi-squared test was used to analyze the association between LAMC2 level and clinical parameters, the Cox proportional hazards regression model was used to evaluate the hazard ratio for death, and Kaplan-Meier analysis with a log-rank test was used for the survival analysis.RESULTS:LAMC2 was overexpressed in PSCC tissues, and the LAMC2 expression level was higher in metastatic lymph node (LN) tissues than in primary cancer tissues; moreover, the LAMC2 levels in primary cancer tissues and sLAMC2 were higher in patients with LN metastasis than in those without LN metastasis. Upregulated LAMC2 facilitated the migration, invasion, and epithelial-to-mesenchymal transition of PSCC cells in vitro and promoted LN metastasis of PSCC cells in nude mice. Elevated LAMC2 levels were strongly correlated with advanced clinicopathologic parameters, especially LN metastasis, in PSCC patients and predicted shorter disease-specific survival. The predictive value of sLAMC2 is superior to that of C-reactive protein and squamous cell carcinoma antigen previously reported in PSCC patients, and a stratification analysis revealed that the level of sLAMC2 had a higher predictive value for disease-specific survival in early penile cancer (especially at the N0/X stage) than in later-stage penile cancer.CONCLUSION:These findings suggest that sLAMC2 is a potential serologic prognostic marker in PSCC and could aid in risk stratification in early-stage PSCC patients.

LAMC2 Acts As a Novel Therapeutic Target of Cetuximab in Laryngeal Cancer.

LAMC2 Promotes EGFR Cell Membrane Localization and Acts As a Novel Biomarker for Tyrosine Kinase Inhibitors (tkis) Sensitivity in Lung Cancer

Silencing of LAMC2 Reverses Epithelial-Mesenchymal Transition and Inhibits Angiogenesis in Cholangiocarcinoma Via Inactivation of the Epidermal Growth Factor Receptor Signaling Pathway

LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway

LAMC2 as a prognostic biomarker in human cancer: a systematic review and meta-analysis

LAMC2 promotes the proliferation of cancer cells and induce infiltration of macrophages in non-small cell lung cancer

Knockdown of Long Noncoding RNA CCAT2 Suppresses Malignant Phenotype in Human Laryngeal Squamous Cell Carcinoma

LAMC2 enhances the metastatic potential of lung adenocarcinoma

Elevated Serum LAMC2 is Associated with Lymph Node Metastasis and Predicts Poor Prognosis in Penile Squamous Cell Carcinoma.

Oncogenic Roles of Laminin Subunit Gamma‐2 in Intrahepatic Cholangiocarcinoma Via Promoting EGFR Translation

LAMC1 is a Novel Prognostic Factor and a Potential Therapeutic Target in Gastric Cancer

CDCA2 Promotes Lung Adenocarcinoma Cell Proliferation and Predicts Poor Survival in Lung Adenocarcinoma Patients

EGFR, HER2, and HER3 Expression in Laryngeal Primary Tumors and Corresponding Metastases

Overexpression of LAMC2 Predicts Poor Prognosis in Colorectal Cancer Patients and Promotes Cancer Cell Proliferation, Migration, and Invasion.

LncRNAs-Regulated High Expression of LAMC2 Reveals a Prognostic and Immunological Value in Pancreatic Adenocarcinoma.

LAMC2 mitigates ER stress by enhancing ER-mitochondria interaction via binding to MYH9 and MYH10

ABCG2 Regulated by MAPK Pathways is Associated with Cancer Progression in Laryngeal Squamous Cell Carcinoma.

Overexpression of laminin-5 gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR/ERK1/2/AKT/mTOR cascade

The Expression and Therapeutic Potential of Checkpoint Kinase 2 in Laryngeal Squamous Cell Carcinoma

CEACAM5 Inhibits the Lymphatic Metastasis of Head and Neck Squamous Cell Carcinoma by Regulating Epithelial–mesenchymal Transition Via Inhibiting MDM2

Role of Epithelial-Mesenchymal Transition Markers E-cadherin, N-cadherin, Β-Catenin and ZEB2 in Laryngeal Squamous Cell Carcinoma